Sudden unexpected cardiac death

European Heart Journal

Volumn 23, Issue 23, 2002, Pages 1797-1798

  Oliver, M F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; NICOTINIC ACID DERIVATIVE; OMEGA 3 FATTY ACID; POTASSIUM; RANOLAZINE;

ACUTE HEART INFARCTION; CLINICAL TRIAL; DEFIBRILLATOR; DRUG EFFECT; DRUG EFFICACY; EDITORIAL; FIRST AID; GLUCOSE INFUSION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HUMAN; INSULIN INFUSION; ION EXCHANGE; PATHOGENESIS; PRIORITY JOURNAL; RESUSCITATION; RISK FACTOR; SUDDEN DEATH;

AGED; DEATH, SUDDEN, CARDIAC; HUMANS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; VENTRICULAR FIBRILLATION;

EID: 0036892195     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2002.3373     Document Type: Editorial

References (19)

1. Lawrie DM, Higgins MR, Godman MJ, Oliver MF, Julian DG, Donald KW. Ventricular fibrillation complicating myocardial infarction. Lancet 1968; ii: 523-8.
2. Myerberg RJ, Kessler KM, Castellanos A. Sudden cardiac death: Epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993; 119: 1187-97.
3. Cobb LA, Fahrenbruch CE, Walsh TR et al. Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation. JAMA 1999; 281: 1182-8.
4. Weiss JP, Saynina O, McDonald KM, McClellan MB, Hlatky MA. Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among Medicare beneficiaries. Am J Med 2002; 112: 519-27.
5. Kurien VA, Oliver MF. A metabolic cause for arrhythmias during acute myocardial hypoxia. Lancet 1970; ii: 813-15.
6. Opie LH. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Am J Cardiol 1975; 36: 938-53.
7. Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of the heart. Ann Rev Physiol 1974; 36: 413-59.
8. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias Lancet 1994; 343: 155-8.
9. Billman GE, Kang JX, Leaf A. Prevention of sudden cardiac death by dietary pure ω-3 polyunsaturated fatty acids in dogs. Circulation 1999; 99: 2452-7.
10. Leaf A. The electrophysiological basis for the antiarrhythmic actions of polyunsaturated fatty acids. Eur Heart J Supplements 2001; 3 (Suppl D): D98-D105.
11. Albert CM, Campos H, Stampfer MJ et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002; 346: 1113-1118.
12. Oliver MF. Metabolic causes and prevention of ventricular fibrillation during acute coronary syndromes. Am J Med 2002; 112: 305-11.
13. Lopashuk GD, Kozak R. Trimetazidine inhibits fatty acid oxidation in the heart. J Mol Cell Cardiol 1998; 30: A112.
14. Bagger JP, Botker HE, Thomassen A, Nielsen TT. Effects of ranolazine on ischemic threshold, coronary sinus blood flow and myocardial metabolism in coronary artery disease. Cardiovasc Drugs Ther 1997; 11: 479-84.
15. GISSI Prevenzione Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447-55.
16. Apstein CS, Opie LH. Glucose-insulin-potassium (GIK) for acute myocardial infarction: A negative study with a positive value. Cardiovasc Drugs Ther 1999; 13: 185-9.
17. Diaz R, Paolasso EC, Piegas LS. Metabolic modulation of acute myocardial infarction. The ECLA Glucose-Insulin-Potassium pilot trial. Circulation 1999; 98: 227-34.
18. Malmberg K, for the DIGAMI group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997; 314: 1512-5.
19. Lopaschuk GD. Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism. Am J Cardiol 1998; 82: 14K-17K.